Renal Function Underpins the Cyclooxygenase-2: Asymmetric Dimethylarginine Axis in Mouse and Man

[1]  D. Fliser,et al.  Cardiovascular Disease in Chronic Kidney Disease , 2021, Circulation.

[2]  J. Mitchell,et al.  Cyclooxygenases and the cardiovascular system. , 2020, Pharmacology & therapeutics.

[3]  W. Wahli,et al.  Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis , 2019, Cardiovascular research.

[4]  J. Mitchell,et al.  Cell-Specific Gene Deletion Reveals the Antithrombotic Function of COX1 and Explains the Vascular COX1/Prostacyclin Paradox , 2019, Circulation research.

[5]  J. Rodriguez-Perez,et al.  Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach , 2019, International journal of molecular sciences.

[6]  E. Karlson,et al.  Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs , 2018, Circulation.

[7]  R. Harris,et al.  Renal Medullary Interstitial COX-2 (Cyclooxygenase-2) Is Essential in Preventing Salt-Sensitive Hypertension and Maintaining Renal Inner Medulla/Papilla Structural Integrity , 2018, Hypertension.

[8]  G. S. Silva Júnior,et al.  Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs , 2018, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[9]  E. Want,et al.  Development of a novel UHPLC-MS/MS-based platform to quantify amines, amino acids and methylarginines for applications in human disease phenotyping , 2018, Scientific Reports.

[10]  J. Mitchell,et al.  Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system , 2018, British journal of pharmacology.

[11]  W. Wahli,et al.  Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARβ/δ-Dependent Vasodilator Pathway , 2018, Hypertension.

[12]  J. Mitchell,et al.  Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A2 Proves Renal Origins of Urinary PGI-M and TX-M , 2018, Circulation research.

[13]  Z. Hei,et al.  Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis , 2017, Scientific Reports.

[14]  S. Richard,et al.  Arginine Methylation: The Coming of Age. , 2017, Molecular cell.

[15]  Rania Nasrallah,et al.  PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes. , 2016, Journal of the American Society of Nephrology : JASN.

[16]  J. Mitchell,et al.  Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  J. Mitchell,et al.  Evidence That Links Loss of Cyclooxygenase-2 With Increased Asymmetric Dimethylarginine , 2015, Circulation.

[18]  E. Lerut,et al.  Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  J. Mitchell,et al.  COX-2 Protects against Atherosclerosis Independently of Local Vascular Prostacyclin: Identification of COX-2 Associated Pathways Implicate Rgl1 and Lymphocyte Networks , 2014, PloS one.

[20]  C. Hao,et al.  Generation of a Tenascin-C-CreER2 Knockin Mouse Line for Conditional DNA Recombination in Renal Medullary Interstitial Cells , 2013, PloS one.

[21]  X. Y. Zhang,et al.  Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials , 2013, BDJ.

[22]  J. Mitchell,et al.  LC-MS/MS Confirms That COX-1 Drives Vascular Prostacyclin Whilst Gene Expression Pattern Reveals Non-Vascular Sites of COX-2 Expression , 2013, PloS one.

[23]  D. Kelsell,et al.  Cryptogenic multifocal ulcerating stenosing enteritis associated with homozygous deletion mutations in cytosolic phospholipase A2-α , 2012, Gut.

[24]  J. Mitchell,et al.  Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system , 2012, Proceedings of the National Academy of Sciences.

[25]  J. Leiper,et al.  Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators? , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[26]  E. Benjamin,et al.  Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community , 2009, Circulation.

[27]  Maristela L Onozato,et al.  Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. , 2007, American journal of physiology. Heart and circulatory physiology.

[28]  G. FitzGerald,et al.  COX-2 inhibitors and cardiovascular risk. , 2007, Journal of cardiovascular pharmacology.

[29]  P. Vallance,et al.  Disruption of methylarginine metabolism impairs vascular homeostasis , 2007, Nature Medicine.

[30]  J. Morrow,et al.  Differentiation of Cyclooxygenase 1- and 2–Derived Prostanoids in Mouse Kidney and Aorta , 2006, Hypertension.

[31]  R. Harris,et al.  COX-2 and the Kidney , 2006, Journal of cardiovascular pharmacology.

[32]  Ying Yu,et al.  Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. , 2006, The Journal of clinical investigation.

[33]  Rania Nasrallah,et al.  Prostacyclin signaling in the kidney: implications for health and disease. , 2005, American journal of physiology. Renal physiology.

[34]  T. Teerlink.  ADMA metabolism and clearance , 2005 .

[35]  Tianxin Yang,et al.  Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. , 2005, American journal of physiology. Renal physiology.

[36]  R. Harris,et al.  Cyclooxygenases, the kidney, and hypertension. , 2004, Hypertension.

[37]  M. Okabe,et al.  Prostacyclin-Deficient Mice Develop Ischemic Renal Disorders, Including Nephrosclerosis and Renal Infarction , 2002, Circulation.

[38]  R. Harris,et al.  Cyclooxygenase-2 in the kidney. , 2000, Journal of the American Society of Nephrology : JASN.

[39]  P. Vallance,et al.  Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. , 1999, Cardiovascular research.

[40]  R. Harris,et al.  Cyclooxygenase-2 in rat nephron development. , 1997, American journal of physiology. Renal physiology.

[41]  J. Johnston,et al.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.

[42]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[43]  J. Vane,et al.  The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: L-glutamine inhibits the generation of L-arginine by cultured endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Jane A. Mitchell,et al.  L-glutamine inhibits the release of endothelium-derived relaxing factor from the rabbit aorta. , 1990, Biochemical and biophysical research communications.

[45]  J. Vane,et al.  Inhibition by l‐glutamine of the release of endothelium‐derived relaxing factor from cultured endothelial cells , 1990, British journal of pharmacology.

[46]  J. Vane,et al.  Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRF. , 1990, European journal of pharmacology.

[47]  C. Thiemermann,et al.  Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. , 1990, Biochemical and biophysical research communications.

[48]  J. Vane,et al.  The generation of L-arginine in endothelial cells is linked to the release of endothelium-derived relaxing factor. , 1990, European journal of pharmacology.

[49]  B. Thornhill,et al.  Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury. , 2007, The American journal of pathology.